e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Current symptom-based risk scores for stable coronary artery disease evaluation are not applicable in COPD patients
Christoph Beyer, Alex Pizzini, Anna Boehm, Judith Loeffler-Ragg, Guenter Weiss, Gudrun Feuchtner, Axel Bauer, Guy Friedrich, Fabian Plank
Source:
ERJ Open Res, 6 (4) 00492-2020; 10.1183/23120541.00492-2020
Journal Issue:
October
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Christoph Beyer, Alex Pizzini, Anna Boehm, Judith Loeffler-Ragg, Guenter Weiss, Gudrun Feuchtner, Axel Bauer, Guy Friedrich, Fabian Plank. Current symptom-based risk scores for stable coronary artery disease evaluation are not applicable in COPD patients. ERJ Open Res, 6 (4) 00492-2020; 10.1183/23120541.00492-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Lipid profile in COPD patients with coronary artery disease comorbidity
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Coronary artery disease risk score calculation and evaluation of statin and antithrombotic drug use among patients admitted with an acute exacarbation of COPD
Source: Annual Congress 2008 - Issues in the management of COPD in the community
Year: 2008
Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications
Source: International Congress 2015 – COPD: notable points
Year: 2015
Comparison of cardiopulmonary exercise test in COPD patients with and without coronary artery disease
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013
Visual estimate of coronary artery calcium predicts cardiovascular disease in COPD
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Underappreciation of coronary artery disease in patients with COPD
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020
Comorbit coronary artery disease is related to worse outcomes in patients hospitalised for COPD exacerbation
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Asthma and COPD in patients with coronary artery disease - The unmet demands
Source: International Congress 2016 – Best abstracts in asthma and COPD
Year: 2016
Difficulties in diagnosis of COPD in patients with advanced peripheral artery disease
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Dyspnea in patients with coronary artery disease: is it related with physiologic measurements?
Source: Eur Respir J 2001; 18: Suppl. 33, 300s
Year: 2001
The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Assessment of pulmonary function stratifies global coronary heart disease risk
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009
Cardiointervalography in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005
Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD)
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Assessment of cardiovascular comorbidity
Source: Eur Respir Mon 2013; 59: 28-49
Year: 2013
The cardiovascular comorbidity and the risk of stroke by means of CHADS2- VASc scale in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Prognostic impact of chronic obstructive pulmonary disease in severe symptomatic aortic stenosis
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept